InsidersTradesSigma
Browse the full record of transactions filed by Gladstone Michael, Director. Officer active across 1 companies, notably Day One Biopharmaceuticals, Inc.. Aggregated, 1 filings have been published. Total volume traded: €10.9m. The latest transaction was disclosed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Michael Gladstone is a Board Member at Day One Biopharmaceuticals, Inc. He is involved in overseeing the company's operations and implementing its strategy. His expertise in the biopharmaceutical sector is a valuable asset for the organization.